The L‐type calcium channel CaV1.3: A potential target for cancer therapy
Journal of Cellular and Molecular Medicine · 2024-10 · 28 (19)
DOI: 10.1111/jcmm.70123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 04.10.2024. Verfasst von Xuerun Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Calcium Channels, L-Type, Neoplasms, Calcium Channel Blockers. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer remains a prominent cause to life expectancy, and targeted cancer therapy stands as a pivotal approach in contemporary therapy. Calcium (Ca 2+ ) signalling plays a multifaceted role in cancer progression, such as proliferation, invasion and distant metastasis. Otherwise, it also exerts an important influence on the efficacy of clinical treatment, including cancer therapy resistance. In this review we discuss the role of the L‐type calcium channel CaV1.3 (calcium voltage‐gated channel subunit alpha1 D) in different types of cancers, highlighting its potential as a therapeutic target for certain cancer types. The development of selective blockers of the CaV1.3 channel has been of great interest and is expected to be a new option for the treatment of cancers such as prostate cancer and endometrial cancer. We present the pharmacological properties of CaV1.3 and the current status of selective blocker development, and analyse the challenges and possible directions for breakthroughs in the development of tailored medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Peking University People's Hospital, Beijing, China.
ORCID-Profile: Xuerun Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Shen, B., Zhou, J., Hao, J., & Wang, J. (2024). The L‐type calcium channel CaV1.3: A potential target for cancer therapy. Journal of Cellular and Molecular Medicine, 28(19). https://doi.org/10.1111/jcmm.70123
Vancouver
Liu X, Shen B, Zhou J, Hao J, Wang J. The L‐type calcium channel CaV1.3: A potential target for cancer therapy. Journal of Cellular and Molecular Medicine. 2024;28(19). doi:10.1111/jcmm.70123
BibTeX
@article{Liu2024,
author = {Liu, Xuerun and Shen, Boqiang and Zhou, Jingyi and Hao, Juan and Wang, Jianliu},
title = {The L‐type calcium channel CaV1.3: A potential target for cancer therapy},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {19},
doi = {10.1111/jcmm.70123}
}
EUVIMED